One of the largest academic publishers in the United States has retracted scientific studies on the risks posed by chemical abortions that are part of an upcoming Supreme Court case, prompting the studies’ authors to accuse the publisher to give in to pro-choice activists.
On February 5, Sage Publishing retracted a 2021 study in the journal Health Services Research and Managerial Epidemiology that found a 507% increase between 2002 and 2015 in emergency room visits after chemical abortions with the pill mifepristone , according to an analysis of Medicaid data.
Another 2022 study published in the same journal that was retracted showed how complications due to chemical abortions are often misclassified as spontaneous abortions and represent “a significant risk factor for subsequent hospital admission.”
One of America’s largest academic publishers has retracted scientific studies on the risks posed by chemical abortions that are part of an upcoming Supreme Court case. Getty Images Both studies were cited in a judge’s decision to suspend the FDA’s approval of mifepristone in April 2023, which was later stayed by the Supreme Court after an appeal by President Biden’s Justice Department. AP
Both studies were cited in U.S. District Judge Matthew Kacsmaryk’s decision to suspend the FDA’s approval of mifepristone in April 2023, a decision that was later stayed by the Supreme Court following an appeal by President Biden’s attorney general. , Elizabeth Prelogar.
Oral arguments in the appeal will be heard on March 26.
The FDA and the American College of Obstetricians and Gynecologists have said that mifepristone is “safe” and “effective” for terminating pregnancies up to 70 days of gestation.
After Kacsmaryk’s ruling, the studies’ co-lead author James Studnicki told The Post that he had received a note of concern from Sage in July 2023 that cited “possible issues related to the representation of data in the paper and conflicts of interests of the author. ”, as well as a conflict of interest with one of the original peer reviewers.
Sage Publishing retracted a study that found a 507% increase between 2002 and 2015 in emergency room visits after chemical abortions with the pill mifepristone, according to an analysis of Medicaid data. Wise Posts
Studnicki and his co-authors knew nothing about the person who had reported the concerns, who was revealed in a States Newsroom article as Chris Adkins, a professor at Southern University’s School of Pharmacy, and were told later that year that both studies had been retracted. .
The journal Health Services Research and Managerial Epidemiology also expelled Studnicki from its editorial board without explanation.
In a response letter, Studnicki harshly criticized Sage for the decision, saying that no findings from the studies had been “explicitly questioned, much less invalidated,” that there was “no evidence of error, miscalculation, fabrication or falsification.” , that the criteria for retraction requests had not been met according to publication guidelines and therefore withdrawing the studies was “demonstrably unjustified.”
Studnicki and two other co-authors, Tessa Longbons and Dr. Ingrid Skop, are affiliated with the Virginia-based Charlotte Lozier Institute, an anti-abortion research organization, which they revealed on the cover of the studies. @InstitutoLozier/X
Sage’s retraction notice states that the two studies and another article did not meet the standards of the Committee on Publication Ethics (COPE) and that a post-publication peer review had found “fundamental problems with the design and methodology of the study” that “demonstrate[d] lack of scientific rigor and invalidate[d] the authors’ conclusions in whole or in part.
Studnicki and two other co-authors, Tessa Longbons and Dr. Ingrid Skop, are affiliated with the Virginia-based Charlotte Lozier Institute, an anti-abortion research organization, which they revealed on the cover of the studies.
Studnicki is currently the group’s vice president of data analytics, and Skop, who serves as vice president of medical affairs, is a board-certified obstetrician-gynecologist with more than 30 years of experience. Longbons is a senior research associate.
Dr. Ingrid Skop said she believes she and her research colleagues were “targeted.” CQ-Roll Call, Inc via Getty Images
They all told The Post that the retractions were “unprecedented,” and Studnicki said the expression of concern seemed like someone was “trying to harass us.”
“I have worked for 50 years as an academic at three different universities and have never been involved in a retraction,” Studnicki said. “There is absolutely no, nothing, no suggestion that this science is in any way inadequate or flawed.
Longbons said: “It also feels like a double standard, because of course one of the arguments they made was that we didn’t disclose our conflicts of interest.
“And none of us make much money doing the work we’re doing. But still, these researchers who work for the Guttmacher Institute and other very vocal pro-abortion organizations never report their conflicts.”
The FDA’s case for approval of mifepristone is still under appeal. AFP via Getty Images
Skop also said of her research into the potential risks of complications from chemical abortion: “It undermines their narrative that it is so safe.
“And clearly, I think that’s why we were attacked.”
Longbons said: “This incident points to a newer and broader phenomenon, which is that many of our scientific institutions and publications no longer champion open research.
“Rather, we are seeing a biased elite faction throughout the medical community with all the power attempting to suppress any research that goes against their approved pro-abortion narrative. “Scientific research and publication should be based on science and not driven by ideology.”
The Post has contacted Sage representatives for comment.
Categories: Trending
Source: vtt.edu.vn